| abstract |
The present disclosure relates generally to pharmaceutical compositions and combinations comprising an androgen receptor modulator or inhibitor and a second therapeutically active agent, such as an antiandrogen. In particular, the present disclosure relates to pharmaceutical compositions and combinations useful for the treatment of various cancers, such as breast and prostate cancer. |